Karsten Mäder
Impact in
- Pharmaceutical Science top 0.05%
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Drug Solubulity and Delivery Systems
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Advanced Drug Delivery Systems 31
- Drug Solubulity and Delivery Systems 29
- Co-authors
- W. Mehnert (4 shared papers)Sabine Kempe (6 shared papers)H. Metz (21 shared papers)Gerd Hause (15 shared papers)Jörg Kreßler (21 shared papers)Andreas Briel (2 shared papers)Thomas Mueller (16 shared papers)Ahmed Besheer (8 shared papers)
- Journals
- International Journal of Pharmaceutics (22 papers)European Journal of Pharmaceutics and Biopharmaceutics (22 papers)Journal of Controlled Release (17 papers)Pharmaceutical Research (12 papers)Pharmaceutics (10 papers)
- Partner nations
- GermanySwitzerlandUnited States
In The Last Decade
Karsten Mäder
195 papers receiving 7.3k citations
Karsten Mäder's Hit Papers
Peers
Comparison fields: 5 of 150
- Pharmaceutical Science 2.7k
- Biomaterials 1.9k
- Molecular Medicine 569
- Biophysics 479
- Food Science 1.0k
Countries citing papers authored by Karsten Mäder
This map shows the geographic impact of Karsten Mäder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Mäder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Mäder more than expected).
Fields of papers citing papers by Karsten Mäder
This network shows the impact of papers produced by Karsten Mäder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Mäder. The network helps show where Karsten Mäder may publish in the future.
Co-authors
The 25 scholars most cited alongside Karsten Mäder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 200 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Solid lipid nanoparticles Hit paper breakdown → | 2012 | 680 |
| 2 | 2004 | 331 | |
| 3 | 2012 | 255 | |
| 4 | 2009 | 238 | |
| 5 | 1999 | 185 | |
| 6 | 2000 | 168 | |
| 7 | 2011 | 153 | |
| 8 | 2003 | 140 | |
| 9 | 2011 | 139 | |
| 10 | 2007 | 122 | |
| 11 | 2005 | 111 | |
| 12 | 2016 | 109 | |
| 13 | 2006 | 104 | |
| 14 | 2008 | 98 | |
| 15 | 2011 | 98 | |
| 16 | 2022 | 93 | |
| 17 | 2020 | 93 | |
| 18 | 2012 | 89 | |
| 19 | 2009 | 88 | |
| 20 | 2018 | 82 |
About Karsten Mäder
Karsten Mäder is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Biomedical Engineering and Organic Chemistry, having authored 200 papers that have together received 7.5k indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (31 papers), Drug Solubulity and Delivery Systems (29 papers), Nanoparticle-Based Drug Delivery (27 papers), Hydrogels: synthesis, properties, applications (19 papers), Electron Spin Resonance Studies (19 papers), Surfactants and Colloidal Systems (18 papers), Nanoplatforms for cancer theranostics (15 papers) and biodegradable polymer synthesis and properties (13 papers). The work is most often cited by research in Pharmaceutical Science (2.7k citations), Biomaterials (1.9k citations), Molecular Medicine (569 citations), Biophysics (479 citations) and Food Science (1.0k citations). Karsten Mäder has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include W. Mehnert, Sabine Kempe, H. Metz, Gerd Hause, Jörg Kreßler, Andreas Briel, Thomas Mueller, Ahmed Besheer, Harold M. Swartz and Thomas Kissel. Their work appears in journals such as International Journal of Pharmaceutics, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Controlled Release, Pharmaceutical Research and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.